UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER

SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-14049

 

 

    IMS Health Incorporated    

(Exact name of registrant as specified in its charter)

 

 

901 Main Avenue

Norwalk, Connecticut 06851

(203) 845-5200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

    Common Stock, $0.01 par value per share    

(Title of each class of securities covered by this Form)

 

 

    None    

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   ¨
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, IMS Health Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:        March 8, 2010          By:    /s/ DAVID R. CARLUCCI    
        

Name:  David R. Carlucci

Title:     Chief Executive Officer and President

IMS Health (NYSE:RX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more IMS Health Charts.
IMS Health (NYSE:RX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more IMS Health Charts.